SCHEMBL288979

SCHEMBL288979

O=C(O)c1c(F)cc(F)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 5/20 0.46
CES1 P23141 5/20 0.46
HCAR1 Q9BXC0 1/20 0.44
ERN1 O75460 1/20 0.43
HCAR2 Q8TDS4 1/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38
PLK1 P53350 1/20 0.38
PLK3 Q9H4B4 1/20 0.38
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA4 P22748 2/20 0.37
KEAP1 Q14145 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
PDPK1 O15530 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29154306 0.97 CES2 (0.44) CES2CES1HCAR1ERN1HCAR2
SCHEMBL27919032 0.89 CES2 (0.39) CES2CES1HCAR1ERN1HCAR2
SCHEMBL15845615 0.89 CES2 (0.39) CES2CES1HCAR1ERN1HCAR2
Propene SCHEMBL27763929 0.87 ERN1 (0.39) CES2CES1HCAR1ERN1HCAR2
Biphenyl SCHEMBL2838517 0.87 AKR1C2 (0.50) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL31590595 0.85 SPR (0.44) CES2CES1HCAR1ERN1KMT2A
SCHEMBL8466122 0.85 CES2 (0.50) CES2CES1HCAR1ERN1KMT2A
SCHEMBL7011182 0.85 SPR (0.44) CES2CES1HCAR1ERN1KMT2A
SCHEMBL148335 0.84 KEAP1 (0.44) CES2CES1HCAR1ERN1KMT2A
SCHEMBL16460187 0.84 RORC (0.43) CES2CES1HCAR1ERN1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 688 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
CN-120044163-A HPLC analysis and detection method for 2,4, 6-trifluoro benzoyl chloride and related substances thereof 复星万邦(江苏)医药集团有限公司 2025-05-27 CN claimed
CN-119414657-A Fluorine-containing titanium oxide nanoparticle photoresist material, preparation method thereof and application thereof in photoetching technology 山东大学 2025-02-11 CN claimed
WO-2024250497-A1 PHOTOELECTRIC DEVICE AND MANUFACTURING METHOD THEREFOR, AND DISPLAY APPARATUS TCL科技集团股份有限公司 2024-12-12 WO claimed
CN-119095455-A Photoelectric device, preparation method thereof and display device TCL科技集团股份有限公司 2024-12-06 CN claimed
CN-118930882-A Solution processable photo-stimulus response cadmium coordination polymer and preparation and application thereof 天津师范大学 2024-11-12 CN claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
CN-117924270-A Nitration method for passivating aromatic heterocyclic compound 棓诺(苏州)新材料有限公司 2024-04-26 CN claimed
CN-117024263-A Preparation method of 2,4, 6-trifluoro-benzoic acid 黑龙江立科新材料有限公司 2023-11-10 CN claimed
CN-115594665-A Novel preparation method of rasemiptan 北京万全德众医药生物技术有限公司(CN) 2023-01-13 CN claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
US-20040094297-A1 Method for determining the extent of recovery of materials injected into oil wells or subsurface formations during oil and gas exploration and production CORE LABORATORIES LP 2004-05-20 US claimed
US-6659175-B2 Mixing water, buffers, oxidizers, gels, gelation inhibitors, stabilizer and curing agents with tracers, then pumping the mixtures into bores, withdrawing fluids and measuring concentration of labels; well completion efficiency CORE LABORATORIES, INC. 2003-12-09 US claimed
US-20030006036-A1 Mixing water, buffers, oxidizers, gels, gelation inhibitors, stabilizer and curing agents with tracers, then pumping the mixtures into bores, withdrawing fluids and measuring concentration of labels; well completion efficiency CORE LABORATORIES GLOBAL N.V. (NL) 2003-01-09 US claimed
WO-2002095189-A1 METHOD OF DETERMINING THE EXTENT OF RECOVERY OF MATERIALS INJECTED INTO OIL WELLS CORE LABORATORIES L.P. (US) 2002-11-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 CES2 1598/4885CES1 3489/4885HCAR1 2637/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 CES2 2351/4885CES1 3786/4885HCAR1 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.